[Changes in anticoagulant tolerance. II. Effects of cardiac insufficiency and drugs administered for its therapy].
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage; D004232:Diuretics / Q000008:administration & dosage; D004347:Drug Interactions; D004361:Drug Tolerance; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage; D007408:Intestinal Absorption; D014044:Tolbutamide / Q000008:administration & dosage; D014812:Vitamin K / Q000378:metabolism; D014813:Vitamin K Deficiency / Q000150:complications
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D000959:Antihypertensive Agents; D004232:Diuretics; D000960:Hypolipidemic Agents; D014812:Vitamin K; D014044:Tolbutamide
Anderung der Antikoagulantientoleranz. II. Einfluss von Herzinsuffizienz und den dabei angewandten Pharmaka